List of Semifialists

Ph.D. | Post Doc. | Industry



Sr Poster No.  Abstract title
1 P01 A multistage dissolution strategy to mimic biorelevant conditions for different generic products of BCS class II compound with pH dependent solubility.
2 P04 Comparative in-vitro release of Risperidone loaded long acting microspheres with marketed formulation
3 P05 Computational Modeling and Simulation of Alternative Setups for Drug Dissolution
4 P09 Designing, Sintering and Profiling of fixed-dose anti-tuberculosis drugs loaded 3D printlets using selective laser sintering (SLS) additive manufacturing technology
5 P12 Dissolution Assisted Interpretation of High Efficacy of ATIS-ARM-LUM - Long Acting Intramuscular Injection
6 P13 Drug Loading Influences Amorphous-Amorphous Phase Separation (AAPS)-mediated nanodroplet formation during dissolution of Amorphous Solid Dispersions (ASDs)
7 P17 Enhancing Topical Permeability of A Potent Immunosuppressant via Lipidic Nanosystems For Effective Management of Rheumatoid Arthritis
8 P18 Evaluating the efficiency of biphasic media to characterize the dissolution profile of albumin-based injectable nanoparticle.
9 P19 Exploring High Permeation Vesicles-Mediated Transdermal Delivery of Methotrexate for Rheumatoid Arthritis Treatment
10 P21 Exploring the polymer-excipient amalgamation in supersaturable Loratadine ternary amorphous solid dispersion for enhanced in-vitro and in-vivo performance
11 P23 Improvement of Drug Release from Colloidal Silicon Dioxide incorporated Empagliflozin Ocular Insert: monitoring of IOP and IVIVC
12 P29 Ionic Liquid-Based Ionogel for Transdermal Delivery of Etodolac for the Treatment of Rheumatoid Arthritis
13 P32 Modulating Dissolution and Permeability of Acetazolamide through Cocrystallization: Insights from Molecular Dynamics
14 P35 QbD-Driven Development of Sublingual Alfuzosin for Improved BPH Therapy


M.Pharm | Pharm D.



Sr Poster No. Abstract Title
1 M02 Artificial in-vitro Blood-Brain Barrier (BBB) model for preclinical screening
2 M05 Development & evaluation of topical quercetin loaded bilosomal gel formulation for psoriasis
3 M17 Evaluation of Erlotinib ionogel as a non-invasive yet localized breast cancer therapy
4 M19 Exploration of conventional and FDM-mediated 3D printed tablets fabricated using HME based filaments for  pH dependent drug delivery
5 M20 Exploring the Potential of Nanosuspensions in Enhancing the Dissolution Profile and Oral Bioavailability of Gefitinib
6 M21 Exploring the Potential of Polymeric Micellar Gel for Enhancing the Efficacy of Adapalene and  Benzoyl Peroxide for the Treatment of Acne
7 M29 Formulation development and efficacy study of nanoparticles for nose to brain delivery
8 M33 In vitro Release testing (IVRT) method development of Ganciclovir nanocarrier based in situ ophthalmic gel using USP Apparatus Type IV
9 M35 Investigating the Potential of Nanostructured Lipid Carriers in Oral Bioavailability Enhancement of Venetoclax
10 M37 LC-MS/MS Analysis - A Sensitive and Specific Bioanalytical Tool for IVPT Studies by Partial Media Replacement Method - Case Study with 5%w/w Acyclovir Cream
11 M38 Long Acting Aqua Triggered In situ gelling Meloxicam Injection
12 M39 Modified 3D printed dissolution cell of USP type-4 apparatus: Novel approach for accelerated dissolution testing of In-situ gel formulations.


About

A Global Dissolution Research Presentations
Competition for Young Pharmaceutical Researchers.

Follow Us